Skip to main content
  • Saved

made a Post

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing - PubMed

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33875457/

The effectiveness of targeted therapies with tyrosine kinase inhibitors in non-small-cell lung cancer (NSCLC) depends on the accurate determination of the genomic status of the tumour. For this reason, molecular analyses to detect genetic rearrangements in some genes (ie, ALK , ROS1 , ...